drugset / Trial / NCT00483041

A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528

NCT00483041 ↗

Phase 2 Terminated 11 enrolled MedImmune LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the effect of MEDI-528 in adults with atopic asthma.

Timeline

Start
2007-07
Primary completion
2008-10
Completion
2009-06

Outcome

Outcome not reported

Stopped: “Study is replaced by MI-CP198 per CPM.”

Drugs

EvaluationDrugModalityDoseRoute
Subject ENOKIZUMAB Monoclonal antibody 9 mg/kg Intravenous

Indications